Medication precautions for giritinib (segatan)

Gilitinib is a targeted drug used to treat certain types of acute myeloid leukemia (AML). It blocks the proliferation and survival of leukemia cells by inhibiting the activation of the FLT3 receptor, thereby slowing down the progression of the disease. When using giritinib to treat AML, patients need to follow a series of medication precautions to ensure the effectiveness and safety of the treatment. The following is a detailed introduction to the medication precautions of giritinib:

1.Doctor's instructions: Patients should carefully read the drug instructions provided by medical professionals before using giritinib, and strictly follow the doctor's medication instructions. Before starting treatment, patients should fully understand the dosage, usage, dosage and treatment cycle of the drug.

2.Dosage and usage: Giritinib is usually administered orally at a dose of 120 mg once daily. Patients should take the medicine accurately according to the doctor's recommendations and try to take it at the same time to ensure stable blood concentration of the medicine.

3.Regular monitoring: During geritinib treatment, patients should undergo regular clinical evaluation and monitoring, including blood tests, electrocardiograms, etc. This helps doctors understand the patient's treatment response and drug tolerance in a timely manner and make necessary adjustments.

4.Dose adjustment: The dose of geritinib is usually determined by the doctor based on the patient's specific condition and treatment response, and may need to be adjusted during treatment. Patients should not adjust their medication dosage on their own and must follow their doctor's recommendations.

5.Interactions with other drugs: While taking giritinib, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with giritinib, affecting the absorption, metabolism, and excretion of the drug, so your doctor may need to adjust the dosage of other drugs or choose an alternative drug.

6.Adverse reaction monitoring: During the use of giritinib, patients should pay close attention to possible adverse reactions and report them to their doctors in a timely manner. Common adverse reactions include nausea, vomiting, diarrhea, fatigue, etc., but serious skin reactions, arrhythmias, etc. may also occur, which require prompt treatment.

7.Avoid use during pregnancy and lactation: Giritinib may cause damage to the fetus, so pregnant and lactating women should not use this drug. Female patients should use effective contraceptive measures while taking giritinib.

8.Reasonable diet and lifestyle: During treatment, patients should pay attention to maintaining good eating habits and a healthy lifestyle. A reasonable diet, adequate rest and appropriate exercise can help improve the body's immunity and reduce the occurrence of adverse reactions.

9.Take medication as directed by your doctor: Patients should take giritinib on time and follow the doctor’s instructions during medication. If patients have any questions or concerns, they should consult their doctor promptly.

In general, patients should closely follow their doctor's recommendations and strictly abide by the medication precautions when using gilitinib to treatAML. Regular monitoring, dose adjustment, monitoring of adverse reactions and avoiding interactions with other drugs are all important to ensure the effectiveness and safety of the treatment.